Cardiorenal Syndrome clinical trials at UCSF

1 research study open to eligible people

Cardiorenal syndrome is a condition where heart and kidney problems happen together. UCSF is comparing device support to diuretic therapy for adults admitted with acute heart failure. Researchers at UCSF collect heart and kidney tests to track effects of treatments.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Our lead scientists for Cardiorenal Syndrome research studies include .

Last updated: